A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1

International Journal of Clinical Oncology

Volumn 12, Issue 4, 2007, Pages 295-299

  Nakamura, Rieko ^a   Saikawa, Yoshiro ^a   Kumagai, Koushi ^a   Kiyota, Tsuyoshi ^a   Ohashi, Masaki ^a   Yoshida, Masashi ^a   Kubota, Tetsuro ^b   Kumai, Koichiro ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Combination chemotherapy; Gastric cancer; Liver metastases; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN; DOCETAXEL; IRINOTECAN;

ADULT; ARTICLE; CANCER STAGING; CASE REPORT; COMBINATION CHEMOTHERAPY; HUMAN; LIVER METASTASIS; MALE; PRIORITY JOURNAL; RADIODIAGNOSIS; STOMACH CANCER; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OXONIC ACID; STOMACH NEOPLASMS; TAXOIDS; TEGAFUR;

EID: 34547860895     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0648-4     Document Type: Article

References (27)

1. U Vanhoefer P Rougier H Wike 2000 Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative group J Clin Oncol 18 2648 2657
2. A Ohtsu Y Shimada K Shirao 2003 Randomized phase III trial of fluorouracil alone versus fluororouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: the Japan Clinical Oncology Group Study (JCOG9205) J Clin Oncol 21 54 59
3. K Sugimachi Y Maehara N Horikoshi 1999 An early phase II study of oral S-1, a newly developed 5-fluoropyrimidine derivative for advanced and recurrent gastrointestinal cancers Oncology 67 202 210
4. Y Sakata A Ohtsu N Horikoshi 1998 Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715 1720
5. W Koizumi M Kurihara S Nakano 2000 Phase II study for S-1, a novel derivative of 5-fluorouracil, in advanced gastric cancer Oncology 58 191 197
6. W Koizumi S Tanabe K Saigenji 2003 Phase I/II study of S-1 with cisplatin in patients with advanced gastric cancer Br J Cancer 89 2207 2212
7. SD Bines G England DJ Deziel 1993 Synchronous, metachronous, and multiple hepatic resections of liver tumors originating from primary gastric tumors Surgery 114 799 805
8. S Ambiru M Miyazaki H Ito 2001 Benefits and limits of resection for gastric metastases Am J Surg 181 279 283
9. K Okano T Maeda K Ishimura 2002 Hepatic resection for metastatic tumors from gastric cancer Ann Surg 1 86 91
10. G Pavel Trazov 2000 Transcatheter therapy of gastric cancer metastastic to the liver: preliminary results J Gastroenterol 35 907 911
11. M Iwahashi M Nakamori Tani 2001 Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a case Oncology 61 16 22
12. Y Saikawa Y Akasaka T Kanai 2003 Preoperative combination chemotherapy with S-1 and low-dose cisplatin against highly advanced gastric carcinoma Oncol Rep 10 381 386
13. S Tsujitani K Fukuda N Kaibara 2003 Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer Gastric Cancer 6 50 57
14. T Nakajima K Ohta S Ishihara 1997 Combined intensive chemotherapy and radical surgery for incurable gastric cancer Ann Surg Oncol 4 203 208
15. A Kretzschmar P Reichardt PC Thuss-Patience 2000 Weekly 24-hour infusion of high-dose 5-fluouracil plus folinic acid in combination with mitomycin C for the treatment of advanced gastric cancer Oncology 59 14 17
16. N Boku A Ohtsu Y Shimada 1999 Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer J Clin Oncol 17 319 323
17. I Hyodo T Nishina T Moriwaki 2003 A phase I study of S-1 combined with weekly cisplatin for metastatic gastric cancer in an outpatient setting Eur J Cancer 39 2328 2333
18. S Watanabe T Tanaka T Takeuchi 2002 Advanced gastric cancer with liver metastases successfully treated with S-1. Int J Clin Oncol 7 326 329
19. S Maeda T Sugiura Y Saikawa 2004 Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism Cancer Sci 95 679 684
20. JS Macdonald SR Smalley J Benedetti 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725 730
21. SH Park WK Lee M Chung 2005 Quality of life in patients with advanced gastric cancer treated with second-line chemotherapy Cancer Chemother Pharmacol 12 1 6
22. GP Stathopoulos SK Rigatos G Fountzilias 2002 Paclitaxel and carboplatin in pretreated advanced gastric cancer: a phase II study Oncol Rep 9 89 92
23. JA Ajani J Baker PW Pisters 2002 Irinotecan/cisplatin in advanced, treated gastric or gastroesophageal junction carcinoma Oncology 16 16 18
24. S Shimada Y Yagi M Kuramoto 2003 Second-line chemotherapy with combined irinotecan and low-dose cisplatin for patients with metastatic gastric carcinoma resistant to 5-fluorouracil Oncol Rep 10 687 691
25. AD Roth J Ajani 2003 Docetaxel-based chemotherapy in treatment of gastric cancer Ann Oncol 14 41 44
26. Y Saikawa T Kubota T Takahashi 2005 Is chemoradiation effective or harmful for stage VI gastric cancer patients? Oncol Rep 13 865 870
27. S Mullany PA Svingen SH Kaufmann 1998 Effect of adding the topoisomerase I poison 7-ethyl-10-hydroxycamptothecin (SN-38) to 5-fluorouracil and folinic acid in HCT-8 cells: elevated dTTP pools and enhanced cytotoxicity Cancer Chemother Pharmacol 42 391 399